NCS-382
http://dbpedia.org/resource/NCS-382 an entity of type: Thing
NCS-382 is a moderately selective antagonist for the GHB receptor. It blocks the effects of GHB in animals and has both anti-sedative and anticonvulsant effects. It has been proposed as a treatment for GHB overdose in humans as well as the genetic metabolic disorder succinic semialdehyde dehydrogenase deficiency (SSADHD), but has never been developed for clinical use.
rdf:langString
rdf:langString
NCS-382
xsd:integer
18471775
xsd:integer
1076042318
rdf:langString
NCS-382.png
xsd:integer
200
rdf:langString
-
rdf:langString
changed
xsd:integer
425000054
rdf:langString
changed
rdf:langString
NCS-382 is a moderately selective antagonist for the GHB receptor. It blocks the effects of GHB in animals and has both anti-sedative and anticonvulsant effects. It has been proposed as a treatment for GHB overdose in humans as well as the genetic metabolic disorder succinic semialdehyde dehydrogenase deficiency (SSADHD), but has never been developed for clinical use.
xsd:nonNegativeInteger
4242
rdf:langString
(2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene ethanoic acid